1	ETS1	ETS1	_	_	_	_	_	_	_
2	transactivates	transactivate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	GM-CSF	GM-CSF	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	Jurkat	Jurkat	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	stimulated	stimulate	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	PMA	PMA	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	ionomycin	ionomycin	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	helper	helper	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	results	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	coordinate	coordinate	_	_	_	_	_	_	_
9	expression	expression	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	number	number	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	cytokines	cytokine	_	_	_	_	_	_	_
15	involved	involve	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	differentiation	differentiation	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	proliferation	proliferation	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	haematopoietic	haematopoietic	_	_	_	_	_	_	_
25	system	system	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
2	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
3	factor	factor	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	GM-CSF	GM-CSF	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	one	one	_	_	_	_	_	_	_
9	such	such	_	_	_	_	_	_	_
10	cytokine	cytokine	_	_	_	_	_	_	_
11	whose	whose	_	_	_	_	_	_	_
12	increased	increase	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	results	result	_	_	_	_	_	_	_
15	partly	partly	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	increases	increase	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	transcription	transcription	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Cis-acting	cis-acting	_	_	_	_	_	_	_
2	elements	element	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	NF	NF	_	_	_	_	_	_	_
5	kappa	kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	AP-1	ap-1	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	ETS-like	ets-like	_	_	_	_	_	_	_
11	motifs	motif	_	_	_	_	_	_	_
12	have	have	_	_	_	_	_	_	_
13	been	be	_	_	_	_	_	_	_
14	identified	identify	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	promoter	promoter	_	_	_	_	_	_	_
18	region	region	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	GM-CSF	GM-CSF	_	_	_	_	_	_	_
22	gene	gene	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	which	which	_	_	_	_	_	_	_
25	are	be	_	_	_	_	_	_	_
26	important	important	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	transcriptional	transcriptional	_	_	_	_	_	_	_
29	activity	activity	_	_	_	_	_	_	_
30	following	follow	_	_	_	_	_	_	_
31	PMA	PMA	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	ionomycin	ionomycin	_	_	_	_	_	_	_
34	stimulation	stimulation	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	number	number	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	ETS	ETS	_	_	_	_	_	_	_
6	family	family	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factors	factor	_	_	_	_	_	_	_
10	are	be	_	_	_	_	_	_	_
11	expressed	express	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	including	include	_	_	_	_	_	_	_
17	ETS1	ETS1	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	ELF1	ELF1	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	describe	describe	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	ability	ability	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	these	these	_	_	_	_	_	_	_
8	factors	factor	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	interact	interact	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	site	site	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	GM5	GM5	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	located	located	_	_	_	_	_	_	_
19	within	within	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	CLE0	cle0	_	_	_	_	_	_	_
22	element	element	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	-47	-47	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	-40	-40	_	_	_	_	_	_	_
27	upstream	upstream	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	GM-CSF	GM-CSF	_	_	_	_	_	_	_
31	transcription	transcription	_	_	_	_	_	_	_
32	initiation	initiation	_	_	_	_	_	_	_
33	site	site	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Exogenous	exogenous	_	_	_	_	_	_	_
2	ETS1	ETS1	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	but	but	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	ELF1	elf1	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	can	can	_	_	_	_	_	_	_
9	transactivate	transactivate	_	_	_	_	_	_	_
10	GM-CSF	GM-CSF	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	through	through	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	GM5	GM5	_	_	_	_	_	_	_
15	site	site	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	PMA/ionomycin	PMA/ionomycin	_	_	_	_	_	_	_
20	dependent	dependent	_	_	_	_	_	_	_
21	manner	manner	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Other	other	_	_	_	_	_	_	_
2	unidentified	unidentified	_	_	_	_	_	_	_
3	ETS-like	ets-like	_	_	_	_	_	_	_
4	factors	factor	_	_	_	_	_	_	_
5	present	present	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	Jurkat	Jurkat	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	are	be	_	_	_	_	_	_	_
10	also	also	_	_	_	_	_	_	_
11	capable	capable	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	binding	bind	_	_	_	_	_	_	_
14	GM5	gm5	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Mutation	mutation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	core	core	_	_	_	_	_	_	_
5	ETS	ets	_	_	_	_	_	_	_
6	binding	binding	_	_	_	_	_	_	_
7	site	site	_	_	_	_	_	_	_
8	from	from	_	_	_	_	_	_	_
9	-GGAA-	-ggaa-	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	-GGAT-	-GGAT-	_	_	_	_	_	_	_
12	prevents	prevent	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	binding	binding	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	ETS-like	ets-like	_	_	_	_	_	_	_
17	factors	factor	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	exception	exception	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	ETS1	ETS1	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	GM-CSF	GM-CSF	_	_	_	_	_	_	_
3	promoter	promoter	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	modified	modify	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	way	way	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	be	be	_	_	_	_	_	_	_
11	ETS1	ets1	_	_	_	_	_	_	_
12	specific	specific	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	fully	fully	_	_	_	_	_	_	_
16	responsive	responsive	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	PMA/ionomycin	PMA/ionomycin	_	_	_	_	_	_	_
19	induction	induction	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	addition	addition	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	ETS1	ets1	_	_	_	_	_	_	_
25	transactivation	transactivation	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	presence	presence	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	PMA	PMA	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	ionomycin	ionomycin	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Together	together	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	data	datum	_	_	_	_	_	_	_
4	suggest	suggest	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	ETS1	ets1	_	_	_	_	_	_	_
7	may	may	_	_	_	_	_	_	_
8	be	be	_	_	_	_	_	_	_
9	involved	involve	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	mediating	mediate	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	increased	increase	_	_	_	_	_	_	_
14	GM-CSF	GM-CSF	_	_	_	_	_	_	_
15	production	production	_	_	_	_	_	_	_
16	associated	associate	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	activation	activation	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

